- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | RESONANCE HEALTH LIMITED: Cessation of Quarterly Reporting | 1 | ASX | ||
| 24.07. | Resonance Health Improves Cash Position as Clinical Trial Pipeline Expands | 3 | smallcaps.com.au | ||
| 24.07. | RESONANCE HEALTH LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | - | ASX | ||
| 15.07. | RESONANCE HEALTH LIMITED: Change of Director's Interest Notice - Simon Panton | - | ASX | ||
| 09.06. | RESONANCE HEALTH LIMITED: Liver Fibrosis Device Progress & FY26 Portfolio Webinar | - | ASX | ||
| 27.05. | RESONANCE HEALTH LIMITED: Change of Director's Interest Notice - Dr David Fuller | - | ASX | ||
| 05.05. | Resonance Health Upgrades FY26 Profit Guidance by 30% Amid Strong Operational Performance | 1 | Finance News Network | ||
| RESONANCE HEALTH Aktie jetzt für 0€ handeln | |||||
| 05.05. | RESONANCE HEALTH LIMITED: Profit Guidance Upgrade | - | ASX | ||
| 29.04. | RESONANCE HEALTH LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | - | ASX | ||
| 28.04. | RESONANCE HEALTH LIMITED: Initial Director's Interest Notice - Michael Sistenich | - | ASX | ||
| 28.04. | RESONANCE HEALTH LIMITED: Initial Director's Interest Notice - Dr David Fuller | - | ASX | ||
| 28.04. | RESONANCE HEALTH LIMITED: Director Appointments | - | ASX | ||
| 01.04. | RESONANCE HEALTH LIMITED: Change of Director's Interest Notice - Simon Panton | - | ASX | ||
| 16.03. | RESONANCE HEALTH LIMITED: Receipt of R&D Tax Incentive Refund | 3 | ASX | ||
| 01.03. | RESONANCE HEALTH LIMITED: Application for quotation of securities - RHT | - | ASX | ||
| 27.02. | RESONANCE HEALTH LIMITED: Notification regarding unquoted securities - RHT | - | ASX | ||
| 27.02. | RESONANCE HEALTH LIMITED: Half Year Results Presentation | 1 | ASX | ||
| 27.02. | RESONANCE HEALTH LIMITED: Half Year Results | - | ASX | ||
| 27.02. | RESONANCE HEALTH LIMITED: Half Year Report & Accounts | - | ASX |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEARTFLOW | 42,110 | +0,07 % | Heartflow, Inc.: Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing coronary artery disease (CAD), today reported financial results... ► Artikel lesen | |
| FRESENIUS | 47,080 | -1,22 % | EQS-News: Fresenius SE & Co. KGaA: Fitch Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Rating
Fitch Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an
10.08.2026 / 14:30 CET/CEST
Für den... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,310 | +0,69 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,040 | +0,12 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,310 | -0,08 % | Biotech Stocks At 52-Week Highs - PARK +10%, AVAH +24%, CADL +10% On Q2 Reports, LH, COAG | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 32,280 | +6,04 % | Carl Zeiss Meditec Aktie: UBS zieht die Reißleine | UBS wird für die Carl Zeiss Meditec Aktie deutlich pessimistischer und stuft den Titel von "Neutral" auf "Sell" ab. Gleichzeitig sinkt das Kursziel von 25,00 auf 22,60 Euro. Auch Barclays und Goldman... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 61,73 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| PROGYNY | 26,280 | 0,00 % | Progyny, Inc. Announces Second Quarter 2026 Results | Reports Record Quarterly Revenue, Gross Profit and Adjusted EBITDARobust Selling Season Activity Continues to Reflect Strong Demand for Women's Health, Family Building SolutionsValue Returned to Shareholders... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 13,950 | -0,07 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,415 | 0,00 % | LifeStance Health gains as Hedgeye adds as new long idea | ||
| SANARA MEDTECH | 34,140 | -0,03 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen | |
| BILLIONTOONE | 93,34 | +0,01 % | Diagnostiksektor: BTIG kürt BillionToOne zum Top-Pick | ||
| BETA BIONICS | 17,570 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| GERRESHEIMER | 27,160 | +0,97 % | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
| GENEDX | 78,16 | +0,10 % | GeneDx launches online exome testing for pediatric patients |
Das Unternehmen RESONANCE HEALTH LIMITED kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RESONANCE HEALTH LIMITED finden Sie auf Wallstreet Online.